Research Fellow
Biomedical Engineering · Egypt · 2022-10-20
Proposed Endeavor
The petitioner proposes to leverage her expertise in biomaterials and regenerative tissue engineering to curate novel treatment methods that are minimally harmful and effective for clinical use. Her work focuses on creating molecular drug designs to improve chemotherapy delivery and developing solutions for integrating ligament tissue to treat ACL injuries.
Framework Evaluation
3 of 3 criteria metThe endeavor addresses leading causes of death like cancer and common orthopedic injuries, which has broad implications for U.S. public health and the sports industry.
The petitioner has 7 years of direct research experience and a record of published work cited 60 times by researchers worldwide.
Given the critical nature of her biomedical research and NIH funding, it was found beneficial to the U.S. to waive the labor certification requirement.
Why This Petition Was Approved
Evidence
Similar Cases
Engineer
Materials Science · China
Research Scientist
Biotechnology · China
Postdoctoral Researcher
Biotechnology · Iran
Research Scientist
Research and Development · Taiwan
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-10-20.
Browse all casesAt a Glance
EB-2 (NIW) Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist